Equipment Selection & Process Setup That Gets You Audit-Ready Faster
CDSCO / Schedule M
US FDA cGMP
WHO GMP
ICH Q7 / Q8 / Q9
Pharma · Biotech · Manufacturing
Service Overview
What Is Equipment Selection & Process Setup?
When you’re building or upgrading a pharmaceutical or manufacturing facility, the machines you choose and the way you set up your processes will define your product quality, regulatory status, and profitability for years to come. A poor equipment choice made early can lead to failed qualifications, batches that don’t meet spec, or a full shutdown by regulators.
Equipment selection is the process of identifying the exact machine types, sizes, materials of construction, automation level, and configurations your production needs — aligned with your product type (oral solids, injectables, APIs, biotech, etc.), your batch size, and your regulatory requirements.
Process setup goes further: it means designing the entire manufacturing workflow — from raw material entry to finished product dispatch — so that every step is efficient, documented, validated, and inspection-ready.
Together, these two activities form the backbone of a successful, GMP-compliant manufacturing operation. Whether you’re setting up a new plant in India, upgrading to meet the revised Schedule M deadlines, or building a US FDA-compliant facility for export markets — getting this right the first time saves significant time and money.
- Equipment requirement analysis & URS preparation
- Vendor evaluation and equipment selection
- Process flow design and plant layout planning
- DQ, IQ, OQ, PQ qualification protocols
- GMP documentation — SOPs, logbooks, batch records
- CDSCO/Schedule M compliance (India)
- US FDA / cGMP alignment (USA & export)
- Process validation and risk assessment (FMEA)
- Scalability planning for future capacity
- Training and handover support
The Real Cost of Getting Equipment Selection Wrong
Companies lose millions every year — not because they bought cheap equipment, but because they bought the wrong equipment. Here’s what’s at stake.
Re-qualification Costs
If equipment doesn't meet your URS or GMP requirements, you'll need a full re-qualification cycle — costing 3–6 months and significant budget. This is one of the most common pitfalls in new plant setups.
Regulatory Hold & Batch Failures
Wrong equipment can cause critical process parameters (CPPs) to go out of range, leading to batch rejection, OOS results, and in severe cases, regulatory action or plant shutdown by CDSCO or US FDA.
Capacity Bottlenecks
Equipment that's correctly qualified but sized wrong creates production bottlenecks. Under-sized upstream equipment and over-sized downstream equipment are a hidden drain on throughput and profitability.
Plant Layout Inefficiencies
Poor process design creates unnecessary material movement, cross-contamination risks, and ISO grade violations. Getting the layout right from the start prevents expensive retrofits later.
Documentation Gaps
CDSCO inspectors and US FDA auditors both scrutinize equipment documentation closely. Missing DQ records, expired calibration certificates, or incomplete IQ/OQ reports are among the top audit findings.
Export Market Disqualification
If your equipment setup doesn't meet WHO GMP or ICH standards, your products will be barred from regulated export markets — including the EU, USA, and other SRA-regulated countries.
Our Methodology
Step-by-Step: How We Set Up Your Process
We follow a structured, risk-based approach rooted in ICH Q9 principles and aligned with CDSCO/Schedule M (India) and US FDA cGMP requirements
Product & Process Understanding (Technology Transfer Review)
Before selecting a single piece of equipment, we analyze your product — dosage form, API sensitivity, batch size range, critical quality attributes (CQAs), and critical process parameters (CPPs). This review forms the foundation of every downstream decision and is aligned with ICH Q8 pharmaceutical development principles.
User Requirement Specification (URS) Development
We write a detailed URS that captures your process, regulatory, safety, automation, and maintenance requirements. This document is the legal and technical contract between you and your equipment vendor — and it's required by CDSCO (Revised Schedule M), US FDA (21 CFR Part 211), and WHO GMP. A well-written URS prevents scope creep and ensures your supplier delivers exactly what you need.
Equipment Selection & Vendor Evaluation
Based on the URS, we evaluate multiple vendors using a structured scoring system. Key criteria include regulatory compliance track record, material of construction (MOC) compatibility with your product, automation level, CIP/SIP capabilities, delivery timelines, and references from comparable pharma facilities. We help you avoid common pitfalls — like selecting catalog equipment that looks cheaper but fails to pass qualification.
Process Flow & Plant Layout Design
We design your process flow diagram (PFD), piping & instrumentation diagrams (P&IDs), and plant layout with GMP zone classification in mind. This includes material flow, personnel flow, HVAC zone design, contamination prevention, and cleanroom classification (ISO 5–8 / Grade A–D). The layout is optimized to minimize material handling, prevent cross-contamination, and meet fire safety and EHS standards.
Design Qualification (DQ)
Before any equipment is manufactured or purchased, we perform DQ — formally verifying that the proposed design meets all specifications in the URS and applicable GMP requirements. DQ is the first stage of the qualification lifecycle (DQ → IQ → OQ → PQ) and is required by both CDSCO Schedule M and US FDA guidelines. Skipping DQ is one of the most common causes of re-qualification downstream.
Installation & Operational Qualification (IQ / OQ)
Once equipment is delivered and installed, we execute IQ to verify it was installed exactly per manufacturer specifications and your requirements. Then OQ tests whether the equipment operates correctly across its designed range — checking all functions, safety interlocks, alarms, and controls. Every test is documented with protocols, test records, and deviation reports.
Performance Qualification (PQ) & Process Validation
PQ demonstrates that the equipment consistently performs under real production conditions — using your actual product, process parameters, and batch sizes. This links equipment performance directly to product quality. We then develop a full process validation protocol (prospective or concurrent) per ICH Q7 and FDA Process Validation Guidance (2011), ensuring your process is reproducible and in control.
GMP Documentation, SOPs & Training
We prepare all the GMP documentation your facility needs to operate and pass inspections: SOPs, batch manufacturing records (BMRs), calibration schedules, equipment logbooks, cleaning validation records, and maintenance procedures. We also conduct operator training and handover sessions so your team is confident and inspection-ready.
Regulatory Alignment
India vs USA: Compliance Requirements by Region
Regulatory standards differ between India and the USA. Here’s what applies to your equipment selection and process setup — depending on your market.
| Requirement Area | India (CDSCO / Schedule M) | USA (FDA / CGMP) | Global (WHO / ICH) |
|---|---|---|---|
| Governing Standard | IN India Drugs & Cosmetics Act 1940, Revised Schedule M (2023–24), CDSCO Guidelines | US USA 21 CFR Part 211 (finished dosage), 21 CFR Part 210 (CGMP), FDA Guidance Documents | 🌐 Both WHO TRS 986, ICH Q7, Q8, Q9, Q10, PIC/S standards |
| Equipment Qualification | DQ, IQ, OQ, PQ required for all critical equipment. Validation Master Plan (VMP) mandatory per Revised Schedule M. | DQ, IQ, OQ, PQ required per FDA Equipment Qualification Guidance. Lifecycle approach under 21 CFR. Process Validation Guidance. | WHO GMP requires full DQ–IQ–OQ–PQ lifecycle. ICH Q9 mandates risk-based qualification. |
| Calibration | Traceable calibration to national standards (NPL, India). Periodic recalibration records required per Schedule M. | Calibration against NIST-traceable standards. 21 CFR 211.68 requirement for automatic/mechanical equipment. | WHO TRS 986 requires calibration records with traceability to international standards. |
| Documentation | Electronic records (21 CFR Part 11–equivalent) now expected in Revised Schedule M. BMR, SOPs, logbooks in local/bilingual format acceptable. | 21 CFR Part 11 for electronic records/signatures. Complete audit trails required. FDA expects data integrity as a core focus area since 2021. | WHO Annex 6 (data integrity) guidance aligns with both India and USA requirements. |
| Cleanroom Classification | Grade A, B, C, D (WHO-based). Schedule M specifies cleanroom requirements by dosage form (e.g., Grade A for injectable filling). | ISO 5–8 (aligned with EU GMP Annex 1 for sterile products). FDA aseptic processing guidance (2004) applies. | ISO 14644 is the international reference for both India and USA implementations. |
| Water Systems | Purified Water (PW) and Water for Injection (WFI) per IP/BP/USP standards. Schedule M Section 6 applies. | USP <1231> for water quality. 21 CFR 211.48 for water supply requirements. FDA expects continuous TOC/conductivity monitoring. | WHO TRS 970 Annex 2 covers water systems for pharma manufacturing globally. |
| HVAC & Air Handling | Schedule M mandates HVAC qualification, pressure differentials, and AHU validation. Air change rates by zone must be documented. | FDA expects HVAC validation per ISPE HVAC Guide. 21 CFR 211.46 covers ventilation, air filtration, and temperature control. | ISPE Baseline Guide Vol. 2 (Facilities) used globally as HVAC design reference. |
| Regulatory Inspections | CDSCO + State Drug Controllers conduct joint GMP inspections (risk-based model from Jan 2026). Mandatory for license renewal. | US FDA Pre-Approval Inspections (PAIs) and cGMP inspections for 510(k), NDA, ANDA applicants. Import alert risk for non-compliance. | WHO Joint Assessment Inspections for COPP. WHO GMP certification required for export to many countries from India. |
Who We Serve
Industry Applications
Our equipment selection and process setup services cover a wide range of manufacturing sectors — each with unique regulatory and technical requirements.
Oral Solid Dosage (OSD)
Granulators, tablet presses, capsule fillers, coating pans, blenders, and conveying systems. Process setup for high-speed tablet lines with inline IPC and content uniformity testing.
Injectables & Sterile Manufacturing
Isolators, LAF units, autoclaves, filling lines, lyophilizers, and WFI generation. Grade A/B cleanroom setup and aseptic process validation per CDSCO and US FDA aseptic processing guidance.
Active Pharmaceutical Ingredients (API)
Reactors, centrifuges, dryers, milling systems, and solvent recovery units. ICH Q7 GMP compliance, containment strategy, and process safety evaluation for HPAPI handling.
Biotech & Biologics
Bioreactors, chromatography skids, TFF systems, and fill-finish lines. Process setup for mAbs, cell therapies, vaccines, and biosimilars — aligned with ICH Q5A/Q5E and US FDA biologics guidance.
Nutraceuticals & Cosmetics
Process equipment selection and GMP setup for nutraceuticals, dietary supplements, and cosmetics — aligned with FSSAI (India) and US FDA 21 CFR Part 111 / 112 as applicable.
Medical Devices & Combination Products
Manufacturing process setup for Class I–III medical devices, combination products, and in-vitro diagnostics. Aligned with CDSCO MDR 2017 (India) and 21 CFR Part 820 QSR (USA).
Project Timeline
Typical Project Timeline
Timelines vary by project scope, but this gives you a realistic picture of what to expect. Proper planning upfront compresses timelines significantly.
Gap Assessment & Scoping
Review current state, identify compliance gaps, define project scope, regulatory pathway, and resource requirements. Deliverable: Gap Assessment Report & Project Plan.
URS, Process Design & Layout
Prepare URS for all critical equipment. Design process flow and plant layout with zone classifications. Review with client and get approval.
Vendor Selection & DQ
Evaluate vendors, conduct factory acceptance tests (FATs) where needed, finalize procurement, and complete Design Qualification documentation.
Equipment Installation & IQ/OQ
Supervise equipment installation, execute IQ and OQ protocols, handle deviations, and prepare qualification reports.
PQ, Process Validation & Documentation
Complete Performance Qualification, run process validation batches, compile all GMP documentation, SOPs, and training records.
Inspection Readiness & Handover
Conduct mock CDSCO/FDA audit, close out all CAPAs, train your team, and hand over a fully inspection-ready, validated facility.
Note: Greenfield pharmaceutical plant setups typically take 12–24 months. The above timeline reflects equipment qualification for a single dosage form line in an existing facility. Complex multi-product facilities or sterile manufacturing setups will require extended timelines.
What We Deliver
Key Documentation Deliverables
Every document we prepare is GMP-grade, audit-ready, and built for long-term compliance — not just to pass a single inspection.
User Requirement Specification
Defines all technical, regulatory, and operational requirements for equipment before procurement.
Validation Master Plan
Master document covering all qualification and validation activities — required by CDSCO and US FDA.
Design Qualification Report
Formal verification that equipment design meets URS. The first stage of the qualification lifecycle.
Installation Qualification Report
Documents that equipment was installed correctly per manufacturer specs and regulatory requirements.
Operational Qualification Report
Verifies that equipment operates within defined parameters under all expected operating conditions.
Performance Qualification Report
Confirms equipment performs consistently under actual production conditions with your product.
Standard Operating Procedures
Written procedures for operation, cleaning, maintenance, calibration, and changeover of all equipment.
Batch Manufacturing Records
Complete production records for each batch — required by CDSCO, US FDA, and WHO for traceability.
Real-World Success
Case Study: API Plant Setup for a Mid-Size Indian Pharma Company
Case Study — India | CDSCO / Schedule M | WHO GMP Export
A mid-size pharmaceutical company in Hyderabad approached our team to set up a new API manufacturing block for a cardiovascular drug — targeting both domestic CDSCO compliance and WHO GMP certification for export to regulated markets in Africa and Southeast Asia. They had purchased equipment without a formal URS and were 4 months behind schedule, with pending GMP inspection.
The Challenge
Equipment had been procured without DQ documentation. Process flow design didn’t account for solvent containment requirements. IQ/OQ protocols were missing for 6 critical equipment items. Facility had no VMP, and the validation team was under-resourced. CDSCO inspection was scheduled in 90 days.
Our Approach
We conducted a rapid gap assessment in Week 1. Prepared retrospective DQ documentation based on FAT records and vendor manuals. Redesigned process flow for solvent containment compliance. Executed IQ/OQ for all critical equipment in parallel tracks. Prepared VMP, SOPs, and calibration records within 60 days. Conducted a mock CDSCO inspection 2 weeks before the actual audit.
Regulatory Outcome
Facility passed CDSCO GMP inspection with zero critical findings and only 2 minor observations — both resolved within 30 days. WHO GMP certification was granted 5 months later, opening export to 12 new countries.
Avoid These Pitfalls
7 Common Mistakes in Equipment Selection & Process Setup
These are the most frequent and most costly mistakes we see — across Indian MSMEs and US-based manufacturers alike.
1. Buying Equipment Without a URS
Purchasing based on price or sales pitch rather than documented requirements leads to mismatched equipment that fails qualification — or requires expensive customization.
✓ Fix: Always write the URS first, then issue RFQs to vendors.
2. Skipping Design Qualification (DQ)
DQ is often seen as optional but it's the most valuable step — catching design problems before equipment is built or installed, when corrections are cheapest.
✓ Fix: Always write the URS first, then issue RFQs to vendors.
3. Underestimating HVAC & Cleanroom Requirements
Many Indian MSMEs upgrade equipment but fail to upgrade their HVAC systems. The Revised Schedule M now mandates HEPA filters and cleanroom classification for most dosage forms.
✓ Fix: Always write the URS first, then issue RFQs to vendors.
5. Treating Validation as a One-Time Event
Both CDSCO and US FDA expect ongoing process monitoring and periodic requalification. Facilities that stop after initial validation quickly fall out of compliance.
✓ Fix: Always write the URS first, then issue RFQs to vendors.
1. Designing Rooms Before Defining Process Flow
The most common mistake: drawing rooms and corridors before mapping product, material, and personnel flow. This almost always creates cross-contamination risks or inefficient layouts that regulators flag immediately.
✓ Fix: Always write the URS first, then issue RFQs to vendors.
7. Not Planning for Scale-Up
Equipment selected for a 50 kg batch may not scale to a 500 kg batch without significant process re-development. Scalability must be part of the URS.
✓ Fix: Always write the URS first, then issue RFQs to vendors.
1. Designing Rooms Before Defining Process Flow
The most common mistake: drawing rooms and corridors before mapping product, material, and personnel flow. This almost always creates cross-contamination risks or inefficient layouts that regulators flag immediately.
✓ Fix: Always write the URS first, then issue RFQs to vendors.
Why traccglobal
Why Choose traccglobal for Your Equipment & Process Setup?
We’re not a generic consulting firm. We specialize in pharmaceutical, biotech, and manufacturing compliance — with hands-on experience in India and the USA.
Deep Regulatory Expertise — India & USA
Our team has hands-on experience with CDSCO/Schedule M inspections, US FDA Pre-Approval Inspections (PAIs), WHO GMP audits, and ICH guideline implementation. We know what inspectors look for — and we build your documentation to pass.
End-to-End Service — From URS to Handover
We don't just give you a report and leave. We stay with you from initial gap assessment through equipment selection, qualification, process validation, documentation, and mock audit — delivering a truly turnkey solution.
Risk-Based, Practical Approach
We apply ICH Q9 risk management principles to prioritize effort and resources. Critical systems get the most rigorous qualification. Non-critical systems get appropriate, proportionate attention. No over-engineering. No under-compliance.
Scalability & Cost Optimization Built In
We help you select equipment that can grow with your business. And we find cost efficiencies — in vendor selection, documentation reuse, and qualification strategies — without cutting corners on compliance.
Proven Track Record — 150+ Successful Projects
We've helped companies ranging from Indian MSME pharma manufacturers to US-based biotech startups set up compliant, validated manufacturing processes. Our case studies span OSD, injectables, APIs, and biologics.
Transparent Communication & On-Time Delivery
We give you clear timelines, regular progress updates, and honest assessments. When there are problems — and there usually are in complex projects — we tell you immediately and present solutions, not excuses.
Got Questions?
Frequently Asked Questions
Answers to the most common questions we get from pharmaceutical, biotech, and manufacturing companies in India and the USA.
What is equipment selection in pharmaceutical manufacturing?
What documents are required for equipment qualification in India under CDSCO/Schedule M?
What is the difference between IQ, OQ, and PQ in pharmaceutical equipment qualification?
What is the Revised Schedule M and how does it affect equipment setup in India?
How long does pharmaceutical facility design and construction take?
Can I select the same equipment for both Indian and US FDA-regulated manufacturing?
How much does equipment selection and process setup consulting cost?
What is process validation and why is it required?
Ready to Build a Compliant, Efficient Facility?
Whether you’re setting up a new plant in India or the USA, upgrading to meet the Revised Schedule M, or preparing for a US FDA inspection — we’re here to help. Talk to our experts today for a free consultation.